Device Sectors
Effective Self-Management of Blood Glucose Can be Achieved by Using Meters With Advanced Features Paired With Diabetes Education
September 23, 2010 6:33 am | by Bio-Medicine.Org | News | CommentsTARRYTOWN, N.Y., Sept. 23 /- According to a new study, people with diabetes, especially those treated with insulin, may achieve optimal blood sugar control when they understand the impact of food on blood sugar and they utilize useful advanced blood glucose meter (BGM) features such as...
Abbott and Reata Pharmaceuticals Announce Agreement to Develop and Commercialize Bardoxolone Methyl for Chronic Kidney Disease Outside the U.S.
September 23, 2010 6:33 am | by Bio-Medicine.Org | News | CommentsAbbott and Reata Pharmaceuticals Announce Agreement to Develop and... -- ABBOTT PARK, Ill. and IRVING, Texas, Sept. 23 /-
Asian Medical Markets Expert to Attend the MD & M Midwest Conference
September 23, 2010 6:32 am | by Bio-Medicine.Org | News | CommentsBETHESDA, Md., Sept. 23 /- Pacific Bridge Medical will be attending the Medical Design and Manufacturing (MD&M) Midwest Conference from September 28-30, 2010, at the Donald E. Stephens Convention Center in Rosemont, Illinois. MD&M Midwest is part of a national conference series...
Corgenix Reports Fiscal 2010 Financial Results
September 23, 2010 6:32 am | by Bio-Medicine.Org | News | CommentsDENVER, Sept. 23 /- Corgenix Medical Corporation (OTC Bulletin Board: CONX ), a worldwide developer and marketer of diagnostic test kits, today filed its fiscal year Form 10-K and reported financial results. The report disclosed that the company's operating results have advanced for the...
Mayo Clinic Research on SurgiCount To Be Presented at Conferences
September 23, 2010 6:32 am | by Bio-Medicine.Org | News | CommentsTEMECULA, Calif., Sept. 23 /- SurgiCount Medical, the wholly-owned operating subsidiary of Patient Safety Technologies, Inc. (OTC Bulletin Board: PSTX ), announced that results of independent, unsponsored clinical research conducted by the Mayo Clinic on their multi-year effort to reduce...
Latin American Aortic Stent Graft Market to Reach Over $150 Million by 2015, According to Millennium Research Group
September 23, 2010 6:32 am | by Bio-Medicine.Org | News | CommentsTORONTO, Sept. 23 /- According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, Latin American physicians will increasingly adopt abdominal and thoracic endovascular aortic repair in place of surgical repair through 2015 as awareness of...
The New Face of Body Contouring
September 23, 2010 6:32 am | by Bio-Medicine.Org | News | CommentsLOUISVILLE, Colo., Sept. 23 /- As technologies for fat removal become more advanced, physicians now have a superior choice in not only reshaping the body but also recycling the fat to further enhance appearance. According to the most recent statistics from the American Society for...
Beardsworth® Selects OmniComm Systems® AE Reporting System
September 23, 2010 6:31 am | by Bio-Medicine.Org | News | CommentsFORT LAUDERDALE, Fla., Sept. 23 /- OmniComm Systems, Inc. (OTC: OMCM), one of the fastest growing companies in the EDC marketplace, today announced that Beardsworth, a full service contract research organization (CRO) who specializes in difficult therapeutic areas, has selected OmniComm's...
Contact System Has Integrated Isolation Seals
September 23, 2010 6:22 am | Bal Seal Engineering, Inc. | Product Releases | CommentsBal Seal Engineering Inc., a global provider of custom-engineered sealing, connecting, and conducting solutions, has announced plans to launch the world’s first integrated seal and electrical contact system for active implantable devices.
ENTrigue Surgical, Inc. Announces Initial Clinical Experience with Ventera™ Sinus Dilation Systems and the Commercial Launch of Synaero™ Hemostasis Product
September 23, 2010 5:25 am | News | CommentsSAN ANTONIO, Sept. 23 /PRNewswire/ -- ENTrigue Surgical, Inc. ("ENTrigue"), a San Antonio, Texas-based company that designs, develops, manufactures and distributes medical devices used for Ear, Nose and Throat surgical procedures, announced today the first clinical experience with its Ventera™ sinus dilation systems.
Surefil Emerges from Chapter 11
September 23, 2010 3:33 am | by Bio-Medicine.Org | News | CommentsGRAND RAPIDS, Mich., Sept. 23 /- Surefil, a contract manufacturer of liquid-fill products for the personal care, home care, oral care, medical industries, and energy drinks, emerged from Chapter 11 protection with Federal Court approval on September 15, 2010. The company was able to...
GSMA's Global Mobile Awards To Recognise Mobile Innovation in the mHealth Sector
September 23, 2010 3:33 am | by Bio-Medicine.Org | News | CommentsLONDON, Sept. 23 /- The GSMA, which represents the interests of the worldwide mobile communications industry, has launched its prestigious 16th Annual Global Mobile Awards programme. New categories have been added to recognise excellence, achievement and innovation in the broad and...
Ultrasonix Announces New Digital Ultrasound Exam Recording Technology
September 23, 2010 3:32 am | by Bio-Medicine.Org | News | CommentsRICHMOND, British Columbia, Sept. 23 /- Ultrasonix Medical Corporation, a leading developer and manufacturer of high quality diagnostic ultrasound imaging systems is pleased to announce today the introduction of SonixVCR, a software-based innovation that records, stores, and exports...
DuPont and DSM Announce Joint Venture in Surgical Biomedical Materials
September 23, 2010 1:33 am | by Bio-Medicine.Org | News | CommentsWILMINGTON, Del., and HEERLEN, Netherlands, Sept. 23 /- DuPont (NYSE: DD ) and Royal DSM N.V. announce an agreement to form a joint venture to develop, manufacture and commercialize advanced surgical biomedical materials, pending European Union regulatory approval. The joint venture will...
US and EU Regulatory Submissions for Vandetanib in Advanced Medullary Thyroid Cancer Accepted for Review
September 23, 2010 1:32 am | by Bio-Medicine.Org | News | CommentsLONDON, Sept. 23 /- AstraZeneca today announced that the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have accepted regulatory submissions for review of the investigational drug vandetanib in the treatment of patients with advanced medullary thyroid cancer...
70 percent of women likely to experience sexual problems after breast cancer
September 22, 2010 11:32 pm | by EurekAlert | News | Comments(Wiley-Blackwell) A new study published in the Journal of Sexual Medicine looked at whether women were more likely to experience sexual problems after breast cancer. The results showed that 70 percent of women were facing sexual function problems approximately two years post diagnosis.
MicroRNA Panel Provides a More Precise Lung Cancer Diagnosis(2)
September 22, 2010 3:32 pm | by AACR | News | CommentsDENVER — A test based on a panel of microRNAs under development by Rosetta Genomics, Ltd., in Rehovot, Israel, may allow for more precise diagnosis and better targeted therapy for patients with lung cancer.
Transcatheter Aortic Valve Implantation Shows Promise for Patients Too Sick for Conventional Surgery
September 22, 2010 1:32 pm | by University Of Pennsylvania | News | CommentsJust released data from a clinical trial shows promise for a new minimally invasive treatment option for patients with severe aortic stenosis who are too sick for traditional forms of open-heart surgery. As compared to standard medical therapy, the new procedure, transcatheter aortic...
Neuro Kinetics to Showcase Enhanced Control & Analysis Software at Otolaryngology Conference
September 22, 2010 9:32 am | by Bio-Medicine.Org | News | CommentsPITTSBURGH, Sept. 22 /- Neuro Kinetics, Inc. (NKI) ( www.neuro-kinetics.com ), manufacturers of noninvasive medical diagnostic equipment used worldwide to test for vestibular and neurological conditions, said today that it will demonstrate its recently enhanced VEST™ control...
Florida Osteopathic Physicians to Learn Value of VAP® Cholesterol Test at Annual Seminar
September 22, 2010 9:32 am | by Bio-Medicine.Org | News | CommentsBIRMINGHAM, Ala., Sept. 22 /- Atherotech Diagnostics Lab will exhibit its VAP® Cholesterol Test in booth 121 at the Florida Osteopathic Medical Association (FOMA) Mid-Year Seminar held September 24-26 at the Grand Hyatt Tampa Bay in Tampa, Fla. FOMA is the state association for...
AstraZeneca Joins Rochester Initiative to Further Cardiac Safety
September 22, 2010 9:31 am | by Bio-Medicine.Org | News | CommentsROCHESTER, N.Y., Sept. 22 /PRNewswire-USNewswire/ -- AstraZeneca purchased a one-year membership to gain access to an international repository of data designed to aid industry and academic researchers developing new technologies to improve cardiac safety. The database, called the...
Elsevier Launches International Journal of Surgery Case Reports
September 22, 2010 6:34 am | by Bio-Medicine.Org | News | CommentsElsevier Launches International Journal of Surgery Case Reports -- OXFORD, England, September 22, 2010 /-
Endo Pharmaceuticals Receives FDA Priority Review for New Formulation of Long-Acting Oxymorphone Designed to be Crush Resistant
September 22, 2010 6:33 am | by Bio-Medicine.Org | News | CommentsCHADDS FORD, Pa., Sept. 22 /- Endo Pharmaceuticals (Nasdaq: ENDP ) announced that it recently received notification from the U.S. Food and Drug Administration (FDA) that Endo's new drug application (NDA) for its new oral formulation of long-acting oxymorphone, which is designed to be...
Precyse Solutions and M*Modal Announce Breakthrough CAC Solution
September 22, 2010 6:33 am | by Bio-Medicine.Org | News | CommentsPITTSBURGH and WAYNE, Pa., Sept. 22 /- At the 82nd AHIMA Convention and Exhibit, Precyse Solutions , a leader in Health Information Management (HIM) services and technologies, and M*Modal , a pioneer of advanced Speech Understanding technology and provider of on-demand conversational...
Neogen Corporation Announces 1st Quarter Results Conference Call
September 22, 2010 6:33 am | by Bio-Medicine.Org | News | CommentsLANSING, Mich., Sept. 16 /- Neogen Corporation (Nasdaq: NEOG ) announces the following Webcast:What: Neogen Corporation 1st Quarter Results WebcastWhen: Thursday, September 23, 2010 @ 11:00 ETWhere: http://www.videonewswire.com/event.asp?id=72328 How: Live over the Internet --...
